Cg-s4 - Helmslip HE-01 PRV Reference : 1000733-4

  The Helmslip improves field survivability upon cardiac failure of helmet users by improving the response window for medical logistics ( motorcyclist building specialists and hazard personel) concievably this sheath could be used as stand alone in situations not needing head trauma protection.
  • The Helmslip is a +/- 1 centimeter thick skull encompassing sheath which is positioned beneath the physical trauma protective layer of the helmet to a snug fit for the stunt cyclist or hazard / worker / mine sweeper.. The sheath is surfaced with a cloth material like cotton which prevents direct skin contact and thereby cold burns from the sub zero sheath. Mammal studies by eastern medics reportedly indicate that brain revival functionality can be optimally prolonged when maintained hypothermically in a range of 5 to 6 degrees celcius the Helmslip is designed for the conducive cooling of the frontal and parietal lobes as much as is practical which deteriorate quickly in abscence of active cooling..
  • The sheath is filled with a fluid / gel liquid blended for high capacity icing to act as a rapid cranium cooler as needed flush to the forehead with maximum cranial contact as allows..
  • A sensor contact switch activates the helmet when in contact with human skin saving the need to switch on and off the active protection initiative by the bearer there is a LCD display to reassure activation and power supply..
  • An inexpensive pulse measuring registers and monitors the bearers pulse.
  • When activated the device monitors for the occurance of cardiac arrest and triggers of non comply arrhythmia indicators over a measure of example 45 second intervals. As with example the common precursor to cardiac arrest on bleeding out of the bearer (a common sceenario) which would register as critically low blood pressure , arrhythmia infractions or slowing to a choke like halt. The DC motor which here is the valve gate regulator opens to release into the sheath pressurised coolant cooling the sheath below zero degrees celsius ideally at a period prior lto arrest allowing the waning but present blood circulation facilitating a rapid cooling of the overall brain , Functioning such the Helmslip should significantly extend the critical time which medical personel has to re-establish blood pressure loss and regain cardiac activity slowing the potential onset of catastrophic brain damage for example of the bleed out casualty and possible transport to mobile theatres to increase a window before the onset of stem fuse reality.
  • The Helmslip has a somewhat rigid frame in the laver of the sheath to hold the socket module reliably in place and sensors in contact with the skin where necessary. Perforations and channels in the framing band need to lend to a even rapid freeze of the Helmslip upon the release of pressurised coolant.
  • The Helmslip can be easily integrated into existing helmet design as the sheath also offering some level of padding which is what is found in many existing constructs. The Socket module could also record and show time of arrest.
  • The originator and propagator of this patent thread is listed submitted initially prior to 2010 Sweden PRV and the patent processing is ongoing having been updated from the onset submitted document.
  NOTES : Very noteworthy with respect to this invention and patent submission was a story on the Swedish National News television report is that pertenent to this idea's concept. The Swedish Ambulance Services is reported recently to have implemented in the field a practice (April 2011) of forcing through the nasal cavity by insertion tube a coolant gas to cool the cranium of patients which the national news reporters claimed was a significant contribution to the survivability for acute patients taken by ambulance to hospital. This may prove to be a complimentary proceedure.

The effectiveness of this equipment can be verified / quantified for elapse judgement by for example neuro doctors respective those interested in it shortly (as is) by primate clinical trials to give findings on this aproach. Being the originator of this proposal I'am not disposed of to be able to evaluate claims I make by reasoning for this product. Primate or mammal clinical trials would give medical staff more information to be able to make lifesaving decisions possibly more sophisticated methodology of which I am not aware. This patent is not solely directed at conflict use but civilian where worker even enthuasts may be engaged in life threatening activities.